Literature DB >> 33475809

[Molecular pathology of tuberculosis : Status, methodology, and limits].

F Stellmacher1, J Kirfel2, B Kalsdorf3,4, F P Maurer5,6, S Perner7,2, T Goldmann7.   

Abstract

In the diagnosis of mycobacterioses, microbiological examination with culture and antibiogram, possibly in combination with molecular biological testing of the fresh material, still represents the gold standard. However, these methods are not available for formalin-fixed paraffin-embedded (FFPE) material or other fixed samples. For this reason, the first step in pathology is to attempt microscopic pathogen detection (ZN/Fite/rhodamine-auramine). Subsequently, molecular pathological examination for the detection of mycobacterial gene sequences should also be considered mandatory today. Although this has clear limits due to the material, it is nevertheless well suited, if carried out correctly, to detect a mycobacterial infection or make it unlikely. A negative result may favor an alternative diagnosis but does not completely rule out mycobacteriosis.For the therapy of tuberculosis or nontuberculous mycobacterial (NTM) disease, the reliable detection of the species and the determination of resistance is of utmost importance. With regard to therapy, the clinician cannot afford to make a false diagnosis. In case of doubt, a rebiopsy for sampling native material, particularly for microbiological testing, should be discussed.

Entities:  

Keywords:  Acid fast bacilli; Auramine; Mycobacterium; Polymerase chain reaction; Sequence analysis

Year:  2021        PMID: 33475809     DOI: 10.1007/s00292-021-00911-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  1 in total

1.  Inter-laboratory validation of PCR-based detection of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissues.

Authors:  Christiane Schewe; Torsten Goldmann; Marianne Grosser; Albert Zink; Karsten Schlüns; Stefan Pahl; Timo Ulrichs; Stefan H E Kaufmann; Andreas Nerlich; Gustavo B Baretton; Manfred Dietel; Ekkehard Vollmer; Iver Petersen
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.